Skip to main content
. 2021 Apr 26;5(5):e564. doi: 10.1097/HS9.0000000000000564

Figure 1.

Figure 1.

Treatment outcome and occurrence of infections and AF. Patients 01 and 07 already had AF before starting ibrutinib, while patients 06 and 10 developed AF after 3 and 55 mo of treatment, respectively. Colored dots indicate the timing and reason for discontinuation of follow-up. AF = atrial fibrillation; Allo-HCT = allogeneic hematopoietic cell transplantation; CR = complete response; G-CSF = granulocyte colony stimulating factor; PR = partial response.